Rangwani Pharmaceuticals Private Limited

Rangwani Pharmaceuticals Private Limited - pharma in Bhopal, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U51909MP2017PTC044065 Incorporated 01 September 2017 ROC Gwalior HQ Bhopal, Madhya Pradesh, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹2.67 Cr
▲ 16% YoY
Net profit · FY 2024
₹8,076
Net margin 0%
EBITDA · FY 2024
₹6.04 Lakh
EBITDA margin 2.3%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Satisfied charges
₹60 Lakh
No open charges
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings

About Rangwani Pharmaceuticals Private Limited

Data last updated:

Rangwani Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 September 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2017PTC044065. Its GSTIN is 23AAICR5003P1Z9 (Madhya Pradesh).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Anjali Rangwani and Deepak Rangwani.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop Lg – 22 – B Lalwani Tower Hamidia Road, Bhopal, Madhya Pradesh, India – 462001.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.67 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹8,076 (net margin 0%) and EBITDA of ₹6.04 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 10% over five years.

As per MCA filings, the company has satisfied charges of ₹60 Lakh on record.

Rangwani Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-10-0000390). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909MP2017PTC044065
Registration Number 044065
Incorporation Date 01 September 2017
ROC Gwalior
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-10-0000390

Recognitions & Rankings of Rangwani Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MP-10-0000390

Contact details

Rangwani Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop Lg – 22 – B Lalwani Tower Hamidia Road, Bhopal, Madhya Pradesh, India – 462001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Rangwani Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Rangwani Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rangwani Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Rangwani Pharmaceuticals Private Limited, buy the company report.

Financials of Rangwani Pharmaceuticals Private Limited

FY 2024 filings available

Rangwani Pharmaceuticals Private Limited reported revenue of ₹2.67 Cr (up 16% YoY) for FY 2024.

Revenue · FY 2024
₹2.67 Cr ▲ 16%
Net profit · FY 2024
₹8,076 margin 0%
EBITDA · FY 2024
₹6.04 Lakh margin 2.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 18%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 15%
5 years · compounded
▲ 22%

Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 16% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.04 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹8,076
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin2.3%
Net Profit Margin0%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rangwani Pharmaceuticals Private Limited, buy the company report.

Board of directors of Rangwani Pharmaceuticals Private Limited

Rangwani Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anjali RangwaniDirector01 Sep 20179 Years 2 MonthsCurrent
Deepak RangwaniDirector01 Sep 20179 Years 2 MonthsCurrent
Kiara RangwaniDirector01 Sep 20179 Years 2 MonthsCurrent

Peer comparison

Rangwani Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
SRK Life Sciences & Research (India) Private Limited₹2.67 Cr (FY 2024)13.0%Mangalore, Karnataka, India
Medcare Marketing Private Limited₹2.67 Cr (FY 2022)1.0%Kochi, Kerala, India
Cameo Health Care (India) Private Limited₹2.67 Cr (FY 2025)40.0%Alto Porvorim, Goa, India
People Hire Purchase & Trading Co Pvt Ltd₹2.67 Cr (FY 2019)-2.0%Shillong, Meghalaya, India
Rangwani Pharmaceuticals Private Limitedthis company₹2.67 Cr (FY 2024)₹8,0760%16.0%Bhopal, Madhya Pradesh, India
Ilkka Healthcare Private Limited₹2.66 Cr (FY 2025)38.0%Bangalore, Karnataka, India
Siddhivinayak Pharmachem Private Limited₹2.66 Cr (FY 2023)-63.0%Mumbai, Maharashtra, India

To see the full peer comparison of Rangwani Pharmaceuticals Private Limited, buy the company report.

Auditor

Rangwani Pharmaceuticals Private Limited is audited by MNB & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MNB & CO.FY 2023016459C

Shareholding

The shareholding of Rangwani Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rangwani Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹60 Lakh
Breakdown by lending institutions
Others₹0.60 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Nov 2017100137517Others₹60 LakhSatisfied

To see the full charge records of Rangwani Pharmaceuticals Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rangwani Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Rangwani Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAICR5003P1Z9Madhya PradeshActive28 Dec 2017

To see the full GST registrations and return filing status of Rangwani Pharmaceuticals Private Limited, buy the company report.

Recent activity

Rangwani Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Anjali Rangwani was appointed as Director on 01 Sep 2017.

Charges
A charge registered on 29 Nov 2017 via Charge ID 100137517 with Others was fully satisfied on 20 Dec 2024.
AGM
Rangwani Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Rangwani Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Charges
A charge with Others of Rs. 60.00 Lakh registered on 29 Nov 2017 with Charge ID 100137517 was modified on 21 Sep 2020.
Charges
A charge with Others amounted to Rs. 60.00 Lakh with Charge ID 100137517 was registered on 29 Nov 2017.
Appointed
Anjali Rangwani was appointed as Director.
Appointed
Deepak Rangwani was appointed as Director.
Appointed
Kiara Rangwani was appointed as Director.
Incorporation
01 Sep 2017
Rangwani Pharmaceuticals Private Limited was registered on 01 Sep 2017 with Roc Gwalior & aged 9 years 2 months as per MCA records.

Frequently asked questions

Rangwani Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 September 2017 (9+ years old) and is registered under CIN U51909MP2017PTC044065.

Rangwani Pharmaceuticals has 3 current directors:

The latest financial statements of Rangwani Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Rangwani Pharmaceuticals is 23AAICR5003P1Z9, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Rangwani Pharmaceuticals is U51909MP2017PTC044065. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rangwani Pharmaceuticals was incorporated on 01 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Rangwani Pharmaceuticals by revenue are SRK Life Sciences & Research (India) Private Limited, Medcare Marketing Private Limited, Cameo Health Care (India) Private Limited, People Hire Purchase & Trading Co Pvt Ltd, Ilkka Healthcare Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Anjali Rangwani was appointed as Director on 01 Sep 2017. Deepak Rangwani was appointed as Director on 01 Sep 2017. Kiara Rangwani was appointed as Director on 01 Sep 2017.

Yes, Rangwani Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-10-0000390).

The registered office of Rangwani Pharmaceuticals is at Shop Lg – 22 – B Lalwani Tower Hamidia Road, Bhopal, Madhya Pradesh, India – 462001.

Rangwani Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.